Abdala- A three-dose regimen of the Abdala candidate vaccine has demonstrated an efficacy of 92.28 percent, placing it well above the World Health Organization (WHO) requirement of at least 50 percent, to be recognized as an anti-COVID-19 vaccine.

CMKC´s English language broadcast. Audio By: Raciel Sanchez Marañon. We have national and international news -from Cuba and around the world – followed by Dr. Jose Rubiera with «The Weather Report.» Susana Nieves brings us our international and national commentaries.